Updated consensus statement for pulmonary rehabilitation of patients with coronavirus disease 2019(2023)  

作　　者：Wenqiao Wang Ye Wang Danye Li Xinqi Ma Tairan Dong Qing Zhao Hongmei Zhao Chen Wang 

机构地区：[1]National Center for Respiratory Medicine/State Key Laboratory of Respiratory Health and Multimorbidity/National Clinical Research Center for Respiratory Diseases/Institute of Respiratory Medicine,Chinese Academy of Medical Sciences/Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China [2]Institute of Basic Medical Sciences,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100005,China

出　　处：《Chinese Medical Journal》2024年第21期2526-2528,共3页中华医学杂志(英文版)

基　　金：supported by the Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences(CIFMS)(No.2021-I2M-1-056);National High Level Hospital Clinical Research Funding(No.2022-NHLHCRF-LX-01).

摘　　要：The global outbreak of coronavirus disease 2019(COVID-19)began toward the end of 2019 and persists as of 2024.[1]Patients infected with COVID-19 may show multiple organ involvement,and body systems can be affected with varying degrees of severity.After acute infection,many patients have physical and psychological symptoms that involve multiple systems and persist for a long time.

关 键 词：PATIENTS INVOLVEMENT ACUTE 

分 类 号：R37[医药卫生—病原生物学]